Adiponectin
OtherWhat is Adiponectin?
Adiponectin is a protein hormone secreted exclusively by adipose (fat) tissue that plays a central role in regulating glucose metabolism, fatty acid oxidation, and inflammation. Paradoxically, despite being produced by fat cells, adiponectin levels are inversely related to body fat—the more adipose tissue a person has (particularly visceral fat), the lower their adiponectin levels. This counterintuitive relationship is due to the inflammatory and hypoxic environment within expanded fat tissue, which suppresses adiponectin gene expression.
Adiponectin circulates in the blood at relatively high concentrations (5–30 mcg/mL) in three forms: low-molecular-weight trimers, medium-molecular-weight hexamers, and high-molecular-weight (HMW) multimers. The HMW form is considered the most biologically active and best predictor of metabolic risk. Adiponectin exerts its effects by binding to two receptors (AdipoR1 and AdipoR2) in liver, muscle, and vascular endothelium, activating AMPK and PPARα signaling pathways. These pathways increase fatty acid oxidation, improve insulin sensitivity, reduce hepatic glucose production, and exert anti-inflammatory and anti-atherogenic effects.
Why It Matters
Adiponectin is one of the most important adipokines (fat-derived hormones) for metabolic health. Low adiponectin levels are consistently associated with insulin resistance, type 2 diabetes, metabolic syndrome, non-alcoholic fatty liver disease, cardiovascular disease, and certain cancers. Unlike most biomarkers that increase with disease, adiponectin decreases—making it a unique "protective" factor whose absence signals increased risk. Higher adiponectin levels are associated with reduced cardiovascular mortality, improved insulin sensitivity, and protection against atherosclerosis. Adiponectin levels are a stronger predictor of future type 2 diabetes than fasting glucose or insulin alone in some studies.
Normal Reference Ranges
| Group | Range | Unit |
|---|---|---|
| Adult Men | 5–25 | mcg/mL |
| Adult Women | 8–30 | mcg/mL |
| Low (metabolic risk) | <4 | mcg/mL |
Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.
What High ADPN Levels Mean
Common Causes
- Normal, healthy metabolic state
- Low body fat percentage
- Regular exercise
- Female sex (women have higher levels)
- Certain medications (thiazolidinediones, fibrates)
- In very high levels: chronic kidney disease, heart failure, anorexia nervosa
Possible Symptoms
- Generally no symptoms—high adiponectin is typically favorable
- If extremely elevated in the context of chronic disease: symptoms of the underlying condition
What to do: High adiponectin is generally a positive finding associated with good metabolic health. No treatment is needed. However, paradoxically high adiponectin in patients with heart failure or advanced kidney disease may reflect adiponectin resistance or sarcopenia (muscle wasting) and has been associated with worse prognosis in these specific populations—this is known as the "adiponectin paradox."
What Low ADPN Levels Mean
Common Causes
- Obesity, especially visceral (abdominal) obesity
- Insulin resistance and metabolic syndrome
- Type 2 diabetes
- Non-alcoholic fatty liver disease
- Coronary artery disease
- Male sex (men have lower levels than women)
- Smoking
- Genetic factors
- Pro-inflammatory state
Possible Symptoms
- Often asymptomatic—detected through laboratory testing
- Features of metabolic syndrome (central obesity, high triglycerides, low HDL)
- Acanthosis nigricans
- Fatigue and sluggishness
- Difficulty losing weight
What to do: Low adiponectin is addressed primarily through lifestyle changes. Weight loss (even 5–10%) significantly increases adiponectin levels. Regular aerobic exercise raises adiponectin independently of weight loss. A Mediterranean-style diet rich in omega-3 fatty acids, fiber, and polyphenols (found in green tea, berries, and dark chocolate) can increase adiponectin. Smoking cessation also improves levels. Thiazolidinedione medications (pioglitazone) potently increase adiponectin but carry their own risks and are prescribed for specific indications.
When Is ADPN Testing Recommended?
- As part of comprehensive metabolic risk assessment
- In evaluating insulin resistance when HOMA-IR is borderline
- When assessing cardiovascular risk in patients with metabolic syndrome
- In research settings evaluating metabolic health interventions
- When non-alcoholic fatty liver disease is suspected or present
- To assess response to weight loss or exercise interventions
Frequently Asked Questions
Related Biomarkers
Want your ADPN levels analyzed?
Upload your lab results for an instant AI-powered breakdown of all your biomarkers.
Upload Lab Results →Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.